[Form 4] Savers Value Village, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV), reported transactions on 09/26/2025. He exercised or acquired 20,000 shares of common stock at an exercise price of $1.41 and simultaneously sold 20,000 shares under a 10b5-1 plan at a weighted average price of $13.6905 (execution prices ranged from $13.48 to $13.87). After these transactions the reporting person shows 0 shares of common stock directly owned.

Table II shows derivative holdings of options representing the right to purchase common stock at $1.41 with 364,256 shares underlying reported as beneficially owned. The filing notes that certain options are time-based (approximately 12%) and performance-based (approximately 88%), with vesting and performance conditions described for the 2019 grant.

Positive

• Sale executed under a 10b5-1 plan, indicating pre-arranged trading and reduced concerns about opportunistic timing
• Weighted average sale price disclosed ($13.6905) with price range ($13.48–$13.87) and offer to provide per-price details, enhancing transparency
• Detailed vesting disclosure for the 2019 option grant, including time-based (~12%) and performance-based (~88%) splits

Negative

• Reporting person holds 0 direct common shares after transactions, which reduces immediate insider equity alignment with shareholders
• Significant number of performance-based options (≈88%) remain subject to future conditions, creating uncertainty about eventual dilution timing

Insights

Securities Analyst

TL;DR: Insider exercised and sold the same number of shares via a 10b5-1 plan, retaining substantial option exposure.

Medway exercised or acquired 20,000 shares at a nominal exercise price of $1.41 and sold those 20,000 shares under a 10b5-1 plan at a weighted average of $13.6905, realizing monetization while recording zero direct common shares after the sale. The filing discloses 364,256 option-based shares outstanding to the reporting person, comprised of time- and performance-based grants from a 2019 plan. For investors this indicates insider liquidity activity without reduction in option-based upside exposure; the sale was pre-planned under a 10b5-1 arrangement and the weighted average sale price range is disclosed.

Corporate Governance Expert

TL;DR: Transaction appears routine and compliant; sale executed under a pre-established 10b5-1 plan.

The report explicitly states the sale was made pursuant to a 10b5-1 plan adopted March 10, 2025, and provides the weighted average sale price range with an offer to supply per-price execution details to regulators or shareholders. The option grant details and vesting schedules from June 12, 2019 are disclosed, including the split between time-based and performance-based awards. This level of disclosure supports compliance and transparency around insider trades and option vesting conditions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Medway Richard A.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
09/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/26/2025		M		20,000	A	$1.41	20,000	D
Common Stock	09/26/2025		S(1)		20,000	D	$13.6905(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(3)	$1.41	09/26/2025		M			20,000	(4)	06/12/2029	Common Stock	20,000	$1.41	364,256(5)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

2. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $13.48 to $13.87. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

3. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

4. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

5. Approximately 12% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 88% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Richard A. Medway report on Form 4 for SVV?

He acquired or exercised 20,000 shares at $1.41 and sold 20,000 shares on 09/26/2025 under a 10b5-1 plan at a weighted average price of $13.6905.

Does the Form 4 show any remaining direct common stock holdings for the reporting person?

No. The filing reports 0 shares of common stock beneficially owned directly following the reported transactions.

How many option-based shares does the reporting person beneficially own after the transactions?

The filing reports beneficial ownership of options underlying 364,256 shares of common stock.

Were the sales made as part of a pre-arranged plan?

Yes. The sale of 20,000 shares was made pursuant to a 10b5-1 plan adopted on March 10, 2025.

What is the exercise price and vesting information for the options mentioned?

Options have an exercise price of $1.41; the June 12, 2019 grant vested in substantially equal annual installments over five years starting March 28, 2020 and was fully vested for certain tranches, with time-based (~12%) and performance-based (~88%) components.